Stock Events

Stock Events

Sangamo Therapeutics (SGMO) Q2 2026 Earnings

14MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.14

-0.09

-0.04

0.01

Details

Expected EPS

0.005

Actual EPS

-0.08

Surprise EPS

-0.09

Surprise Percent

+1,700%

Description

Sangamo Therapeutics (SGMO) has reported earnings of -0.08 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.